Jan 24 (Reuters) - Shire Plc:
* FDA GRANTS APPROVAL TO SHIRE FOR TECHNOLOGY TRANSFER OF CINRYZE® DRUG PRODUCT MANUFACTURING PROCESS TO VIENNA, AUSTRIA MANUFACTURING SITE
* ‍SHIRE WILL BEGIN COMMERCIAL MANUFACTURING OF CINRYZE DRUG PRODUCT IN VIENNA IN Q1 OF 2018​
* ‍CINRYZE WILL ALSO CONTINUE TO BE PRODUCED BY A THIRD-PARTY SUPPLIER, PROVIDING AN ADDITIONAL SUPPLY SOURCE TO MEET PATIENT DEMAND.​ Source text for Eikon: Further company coverage:
 